A Study of Iguratimod in Patients With Active Rheumatoid Arthritis
NCT01554917 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1759
Last updated 2020-10-14
Summary
This study is intended to evaluate the safety and efficacy of Iguratimod in patients with active Rheumatoid Arthritis.
Conditions
Interventions
- DRUG
-
Iguratimod
taken orally, 2 tablets/day (bid)
Sponsors & Collaborators
-
Jiangsu Simcere Pharmaceutical Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Zhanguo Li, MD/PhD · Peking University People's Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-08-31
Countries
- China
Study Locations
More Related Trials
-
Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
NCT06146972 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Iguratimod in Combination With Tofacitinib in RA Patients
NCT06945666 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis
NCT01850966 ·Status: COMPLETED
-
The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA
NCT04928066 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis
NCT00896168 ·Status: COMPLETED ·Phase: PHASE4
-
Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients
NCT03254966 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients
NCT01559103 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
NCT06244628 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis
NCT02151851 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
NCT03025308 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Pharmacokinetics and Safety of SM03 in Patients With Rheumatoid Arthritis
NCT04704492 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
NCT05323591 ·Status: COMPLETED
-
Clinical Trial of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis
NCT07115641 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX
NCT04312815 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
NCT01061736 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011
NCT07295496 ·Status: RECRUITING ·Phase: PHASE1
-
The Treat-to-target Study of RA Based on Smart System of Disease Management(SSDM)
NCT03715595 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis
NCT06754462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
NCT01562327 ·Status: COMPLETED
-
Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
NCT00116714 ·Status: COMPLETED
-
A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis
NCT00853385 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate
NCT04192617 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis
NCT01927263 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044
NCT02319642 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis
NCT01999192 ·Status: TERMINATED ·Phase: PHASE2